Hemosure Revenue and Competitors

Irwindale, CA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Hemosure's estimated annual revenue is currently $8.3M per year.(i)
  • Hemosure's estimated revenue per employee is $251,000

Employee Data

  • Hemosure has 33 Employees.(i)
  • Hemosure grew their employee count by 3% last year.

Hemosure's People

NameTitleEmail/Phone
1
Regional Sales ManagerReveal Email/Phone
2
Western Regional ManagerReveal Email/Phone
3
SE Regional Sales ManagerReveal Email/Phone
4
Regional Sales Manager - Mid-AtlanticReveal Email/Phone
5
Inside Sales RepresentativeReveal Email/Phone
6
PresidentReveal Email/Phone
7
Inside Sales RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Hemosure?

Hemosure, Inc. is a privately held corporation headquartered at Irwindale, California, only 20 minutes away from downtown Los Angeles. The Company is a pioneer in the research and development of one-step rapid membrane tests. It has been designated a registered GMP facility for in vitro diagnostic medical devices by the FDA. Hemosure is established upon over a decade of research in the bio-technological industry. Its scientific professional team has applied these years of R&D experience to their development of one-step membrane immunoassay tests. With the strong support of our sister company, WHPM, Hemosure has continuously researched, developed, and produced high quality rapid test systems that have not only revolutionized the pharmaceutical industry, but have also set new industry standards and guidelines.

keywords:N/A

N/A

Total Funding

33

Number of Employees

$8.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.5M34-24%N/A
#2
$8.1M350%N/A
#3
$3.9M41-2%N/A
#4
$10.7M440%N/A
#5
$8.6M4413%N/A